| Cash Flow | 2026-04-03 | 2025-12-31 | 2025-10-03 | 2025-07-04 |
|---|---|---|---|---|
| Net income | 49,237 | 38,775 | 56,521 | 137,936 |
| Depreciation, amortization and other impairment charges | 23,868 | 25,374 | 21,885 | 36,846 |
| Net gain on sale of property, plant and equipment | 56 | -52 | -6 | 5,703 |
| Pension settlement loss | NaN | 0 | 0 | 0 |
| Stock-based compensation expense | 3,948 | 4,395 | 2,642 | 9,900 |
| Deferred income tax benefit | -4,771 | -27,957 | -946 | -6,761 |
| Amortization of debt issuance costs | 5,764 | 982 | 627 | 1,255 |
| Trade receivables, net | 33,819 | -10,367 | 1,220 | 49,161 |
| Inventories, net | 40,123 | -23,354 | -8,483 | 37,407 |
| Accounts payable | 39,662 | 16,580 | -33,076 | 23,183 |
| Other operating assets and liabilities | -3,205 | -5,131 | -26,555 | 28,051 |
| Net cash provided by operating activities | 46,915 | 97,053 | 81,477 | 82,037 |
| Purchases of property, plant and equipment | 13,703 | 19,633 | 11,180 | 16,474 |
| Proceeds from sale of property, plant and equipment | 275 | 1,804 | -1 | 4,732 |
| Acquisitions, net of cash received | NaN | -1,355 | 353,417 | 86,252 |
| Payment for (proceeds from) other investing activity | NaN | 1,355 | -1,039 | 500 |
| Net cash used in investing activities | -13,428 | -17,829 | -363,559 | -98,494 |
| Proceeds from borrowings on senior notes | 1,000,000 | 0 | 0 | 0 |
| Repayments of borrowings on term loans | 0 | 375,000 | 5,000 | 5,000 |
| Proceeds from borrowings on revolving credit facilities and other | 131,217 | 51,124 | 350,917 | 8,674 |
| Repayments of borrowings on revolving credit facilities and other | 317,374 | 126,707 | 90,442 | 0 |
| Payment of debt issuance costs | 17,017 | 5,396 | 0 | 0 |
| Payment of dividends | 6,092 | 6,092 | 6,092 | 9,729 |
| Distributions to noncontrolling interest holders | 1,117 | 1,114 | 1,883 | 1,174 |
| Other financing | -3,438 | -377 | -590 | -12,418 |
| Net cash provided by (used in) financing activities | 786,179 | -113,562 | 246,910 | -19,647 |
| Effect of foreign exchange rates on cash and cash equivalents | -739 | 1,982 | -4,832 | 44,969 |
| Increase in cash and cash equivalents | 818,927 | -32,356 | -40,004 | 8,865 |
| Cash and cash equivalents, beginning of period | 185,863 | 218,219 | 249,358 | NaN |
| Cash and cash equivalents, end of period | 1,004,790 | 185,863 | 218,219 | NaN |
ESAB Corp (ESAB)
ESAB Corp (ESAB)